Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.

The aim of this study was to evaluate prognostic factors for isolated loco-regional recurrence in patients treated for invasive stage I or II breast cancer. The study population comprised 3602 women who had undergone primary surgery for early stage breast cancer, who were enrolled in European Organisation for Research and Treatment of Cancer (EORTC) trials 10801, 10854, or 10902, by breast conservation (55%) and mastectomy (45%). The median follow-up time varied from 5.3 (range: 0.6-9.5) to 11.9 years (range: 0.6-17.4). Main outcome was the occurrence of isolated loco-regional recurrence. The results of multivariate analysis showed that younger age and breast conservation were risk factors for isolated loco-regional recurrence (breast cancer under 35 years of age versus over 50 years of age: hazard ratio 2.80 (95% CI 1.41-5.60)); breast cancer age 35-50 years versus over 50 years: hazard ratio 1.72 (95% CI 1.17-2.54); breast conservation (hazard ratio: 1.82 (95% CI 1.17-2.86)). After perioperative chemotherapy, less isolated loco-regional recurrences were observed (hazard ratio 0.63 (95% CI 0.44-0.91)). No significant interaction effects were observed. It is concluded that young age and breast conserving therapy are both independent predictors for isolated loco-regional recurrence. As an isolated loco-regional recurrence is a potentially curable condition, women treated with breast conservation or diagnosed with breast cancer at a young age should be monitored closely to detect local recurrence at an early stage.

[1]  H. Bartelink,et al.  Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. , 1992, European journal of cancer.

[2]  M. J. van de Vijver,et al.  Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. , 2005, European journal of cancer.

[3]  M. J. van de Vijver,et al.  Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. , 1998, International journal of radiation oncology, biology, physics.

[4]  M. J. van de Vijver,et al.  High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[6]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[7]  J. Peterse,et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[10]  R. Arriagada,et al.  Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  R. Carlson,et al.  Predictors of local recurrence after breast-conservation therapy. , 2005, Clinical breast cancer.

[12]  T. Delozier,et al.  Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Vicini,et al.  Does local recurrence affect the rate of distant metastases and survival in patients with early‐stage breast carcinoma treated with breast‐conserving therapy? , 2003, Cancer.

[14]  E. Touboul,et al.  Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[15]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[16]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[17]  H. Mouridsen,et al.  Effect of breast‐conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma , 2004 .

[18]  R. Arriagada,et al.  Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  R. Simmons,et al.  Locally recurrent breast cancer after conservation therapy. , 2005, American journal of surgery.

[20]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[21]  C. Redmond,et al.  Significance of ipsilateral breast tumour recurrence after lumpectomy , 1991, The Lancet.

[22]  L. Solin,et al.  Prognosis after regional lymph node recurrence in patients with Stage I–II breast carcinoma treated with breast conservation therapy , 2003, Cancer.

[23]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[24]  L Duchateau,et al.  Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. , 2001, European journal of cancer.

[25]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[26]  J. Coebergh,et al.  Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. , 2004, European journal of cancer.